Only one man (1.0%) from the study population had not performed genetic test, as a BRCA2 VUS has been identified in the index case (brother who had BC), and there is no indication to search for VUS in healthy individuals (NCCN, 2023), although the High-Risk Consultation medical team decided to continue the surveillance program based on his family history of cancer. The gene discussed is BRCA2; the disease is breast cancer.